Correction to: Demonstration of Physicochemical and Functional Similarity of the Biosimilar BAT1806/BIIB800 to Reference Tocilizumab
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Correction to: Demonstration of Physicochemical and Functional Similarity of the Biosimilar BAT1806/BIIB800 to Reference Tocilizumab ; volume:38 ; number:5 ; day:22 ; month:8 ; year:2024 ; pages:725 ; date:9.2024
BioDrugs ; 38, Heft 5 (22.8.2024), 725, 9.2024
- Urheber
-
Liu, Yujie
Xie, Jianhua
Li, Zhuxiang
Mei, Xiong
Cao, Di
Li, Shengfeng
Engle, Linda
Liu, Suli
Ebbers, Hans C.
Liu, Cuihua
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40259-024-00672-3
- URN
-
urn:nbn:de:101:1-2411132133035.651979395872
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Liu, Yujie
- Xie, Jianhua
- Li, Zhuxiang
- Mei, Xiong
- Cao, Di
- Li, Shengfeng
- Engle, Linda
- Liu, Suli
- Ebbers, Hans C.
- Liu, Cuihua
- SpringerLink (Online service)
Ähnliche Objekte (12)
Demonstration of Physicochemical and Functional Similarity of the Biosimilar BAT1806/BIIB800 to Reference Tocilizumab
Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab
Demonstration of Physicochemical and Functional Similarity of Biosimilar Pegfilgrastim-cbqv to Pegfilgrastim
Physicochemical and Functional Similarity Assessment Between Proposed Bevacizumab Biosimilar BAT1706 and Reference Bevacizumab
Assessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to Adalimumab
Demonstration of Functional Similarity of Proposed Biosimilar ABP 501 to Adalimumab
Physicochemical analysis and biological characterization of FKB327 as a biosimilar to adalimumab
Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab
Quality by Design–Based Assessment for Analytical Similarity of Adalimumab Biosimilar HLX03 to Humira®
Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product
Analytical and Functional Similarity of the Biosimilar Candidate ABP 654 to Ustekinumab Reference Product
Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
Demonstration of Physicochemical and Functional Similarity of the Biosimilar BAT1806/BIIB800 to Reference Tocilizumab
Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab
Demonstration of Physicochemical and Functional Similarity of Biosimilar Pegfilgrastim-cbqv to Pegfilgrastim
Physicochemical and Functional Similarity Assessment Between Proposed Bevacizumab Biosimilar BAT1706 and Reference Bevacizumab
Assessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to Adalimumab
Demonstration of Functional Similarity of Proposed Biosimilar ABP 501 to Adalimumab
Physicochemical analysis and biological characterization of FKB327 as a biosimilar to adalimumab
Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab
Quality by Design–Based Assessment for Analytical Similarity of Adalimumab Biosimilar HLX03 to Humira®
Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product
Analytical and Functional Similarity of the Biosimilar Candidate ABP 654 to Ustekinumab Reference Product
Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
Demonstration of Physicochemical and Functional Similarity of the Biosimilar BAT1806/BIIB800 to Reference Tocilizumab
Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab
Demonstration of Physicochemical and Functional Similarity of Biosimilar Pegfilgrastim-cbqv to Pegfilgrastim
Physicochemical and Functional Similarity Assessment Between Proposed Bevacizumab Biosimilar BAT1706 and Reference Bevacizumab
Assessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to Adalimumab
Demonstration of Functional Similarity of Proposed Biosimilar ABP 501 to Adalimumab
Physicochemical analysis and biological characterization of FKB327 as a biosimilar to adalimumab
Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab
Quality by Design–Based Assessment for Analytical Similarity of Adalimumab Biosimilar HLX03 to Humira®
Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product
Analytical and Functional Similarity of the Biosimilar Candidate ABP 654 to Ustekinumab Reference Product